MannKind Corporation to Present at the 31st Annual J.P. Morgan Healthcare Conference
MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at The 31st Annual J.P. Morgan Healthcare Conference on Thursday, January 10, 2013 at 8:00 AM (PST) at St. Francis Hotel in San Francisco, California.